Scientific rigour within a person-centred, biophilic setting
Designed by HDR for Health Infrastructure in collaboration with the Office of the Chief Scientist & Engineer, NSW RNA Bioscience Alliance, Hindmarsh Construction and industry partner and operator Aurora Biosynthetics, the $96 million, 4,500 square metre RNA Research and Manufacturing Facility has opened within the Macquarie University Innovation Precinct.

Intended to translate Ribonucleic Acid (RNA) technologies into clinical-grade vaccines, therapies and diagnostics for viruses, cancers, genetic diseases and other health-related issues, the purpose-built facility — designed to support TGA approval pathways and GMP-aligned operations — includes pDNA and mRNA production suites, lipid nanoparticle encapsulation, pilot-scale fill-and-finish capability, and integrated QA/QC laboratories.

“The facility is designed to evolve alongside emerging scientific technologies, with rapid adaptability and carefully managed visibility into active spaces, maintaining the precision and containment requirements of RNA production,” HDR Project Lead Ady Chen said. “Our approach also grounds the building in its surrounding landscape, creating a humane and restorative environment that supports the wellbeing of the people who work here.”

Setting out to embed scientific rigour within a person-centred, biophilic setting, the facility was conceived as a high-precision pavilion within a grove of mature gum trees. “The building’s horizontal form is articulated with slender vertical elements that reference the surrounding forest and draw natural light deep into the interior,” HDR Design Lead Alan Boswell said. “This creates a calm, grounded environment for complex RNA science, and respects the cultural and ecological character of the site.”

HDR Principal of Education and Science Graeme Spencer said: “Purpose-built environments like this are critical to Australia’s ability to develop RNA-based therapeutics at speed. By bringing flexible pilot manufacturing together with collaborative research spaces, the facility strengthens sovereign capability and supports real-world health outcomes.”

Sydney's $490m commercial life sciences precinct gets first tenants
ION, a dedicated, purpose-built commercial life sciences precinct located in Waterloo, has...
Project PEARL: safety findings of a lab ventilation systems comparison
Could this independent comparison test of lab ventilation systems under real-world stress...
New CSIRO facilities support biodiversity, membrane research
CSIRO has opened a state-of-the-art facility to safeguard more than 13 million biodiversity...
